⏰ TL;DR (Too Long; Didn't Read)

<aside> ☝ METLiT develops AI software that makes Magnetic Resonance Spectroscopy (MRS) data analysis faster, more accurate, and more accessible for researchers and clinicians.

</aside>

💡The Idea

• Magnetic Resonance Spectroscopy (MRS) is an advanced MRI technique that provides a non-invasive, real-time biochemical snapshot of cellular activity. It's used for diagnosing and monitoring various conditions, including brain tumors, dementia, stroke, and pediatric hypoxia
• Currently, MRS data analysis requires the attention and time of multiple MR physicists, limiting its widespread use in clinical settings. This is exacerbated by a global shortage of MRS experts , restricting access to this valuable diagnostic tool.
• METLiT developed AI-powered software for automating MRS data analysis, providing faster and more accurate results.

🥇Benefits

• Reduces analysis time from tens of minutes to 30 seconds
• Increases the number of detectable metabolites (17 vs. 5 in conventional methods)
• Improves accuracy compared to expert human analysis
• Enables wider adoption of MRS in clinical settings
• Provides consistent results even with lower quality data or shorter scan times

💵Business Model

• MRS Analytics (SaaS):
  • Cloud-based software for hospitals and research institutions
  • Subscription model: $1,750 - $3,000 per month
• MRS Research:
  • Consulting and data analysis services for pharma/biotech companies and academic researchers
  • Fee per data: $100 - $300 (compared to $550 - $1,450 for conventional methods)
• MRS Diagnostics (In development):
  • Focus on early diagnosis of dementia, particularly Normal Pressure Hydrocephalus (NPH)
  • Potential for reimbursement: $52 - $1,000 per analysis

🌎Market data